FilingReader Intelligence
Piramal Pharma declares dividend, makes key appointments
July 30, 2025 at 03:59 PM UTC•By FilingReader AI
Piramal Pharma Limited declared a final dividend of ₹0.14 per equity share at its annual general meeting.
The company reappointed Nandini Piramal as a director, along with Amit Jain as a non-executive, non-independent director and Jairaj Purandare as an independent director.
The meeting also approved the issue of non-convertible debentures on a private placement basis.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
BSE:PPLPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when PIRAMAL PHARMA publishes news
Free account required • Unsubscribe anytime